AC
| |
ACORN CAPITAL ADVISORS, LLC13F | |
| ACORN CAPITAL ADVISORS, LLC | |
| Last update 2025-05-19 | 22 Stocks (1 new) |
| Value $150.00 Mil | Turnover 1 % |
ACORN CAPITAL ADVISORS, LLC Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CGON | CG Oncology Inc | 1,131,501 | 27,721.8 | 0% | 18.490 | 0% | 1.480 | +29.60% | -6.73% | 2,039.0 | Biotechnology | |
URGN | UroGen Pharma Ltd | 1,516,303 | 16,770.3 | 0% | 11.180 | 0% | 3.290 | +57.91% | +43.38% | 704.1 | Biotechnology | |
YMAB | Y-mAbs Therapeutics Inc | 3,235,387 | 14,332.8 | +13.05% | 9.560 | +1.10% | 7.150 | -8.10% | -44.96% | 195.2 | Biotechnology | |
TRVI | Trevi Therapeutics Inc | 2,144,844 | 13,491.1 | +7.19% | 9.000 | +0.60% | 2.110 | +13.01% | +66.50% | 835.2 | Biotechnology | |
CADL | Candel Therapeutics Inc | 2,152,252 | 12,160.2 | +10.96% | 8.110 | +0.80% | 4.370 | +47.48% | -22.35% | 337.7 | Biotechnology | |
PBYI | Puma Biotechnology Inc | 3,940,052 | 11,662.5 | 0% | 7.780 | 0% | 7.940 | +18.88% | +11.48% | 168.8 | Biotechnology | |
BCAX | Bicara Therapeutics Inc | 643,382 | 8,383.3 | 0% | 5.590 | 0% | 1.180 | -10.12% | -37.26% | 596.1 | Biotechnology | |
TARA | Protara Therapeutics Inc | 1,279,800 | 5,451.9 | 0% | 3.640 | 0% | 3.320 | -21.03% | -41.67% | 118.8 | Biotechnology | |
TERN | Terns Pharmaceuticals Inc | 1,971,264 | 5,440.7 | 0% | 3.630 | 0% | 2.260 | +135.00% | +1.81% | 492.6 | Biotechnology | |
OKUR | OnKure Therapeutics Inc | 1,439,674 | 5,123.8 | 0% | 3.420 | 0% | 10.660 | -19.38% | -72.91% | 31.5 | Biotechnology |
ACORN CAPITAL ADVISORS, LLC's Historical Top Holdings Breakdowns
ACORN CAPITAL ADVISORS, LLC's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
YMAB | Y-mAbs Therapeutics Inc | 2025-03-31 | Add Add | +1.10% | 4.43 ($5.81) 8.17 | $4.31 | -25.82% | Add 13.05% | 3,235,387 | 373,562 | |
AURA | Aura Biosciences Inc | 2025-03-31 | New Buy New Buy | +0.97% | 5.86 ($7.57) 8.45 | $6.71 | -11.36% | New holding | 590,508 | 590,508 | |
CADL | Candel Therapeutics Inc | 2025-03-31 | Add Add | +0.80% | 5.65 ($8.17) 12.21 | $6.74 | -17.50% | Add 10.96% | 2,152,252 | 212,608 | |
TRVI | Trevi Therapeutics Inc | 2025-03-31 | Add Add | +0.60% | 3.56 ($4.77) 6.81 | $6.86 | 43.82% | Add 7.19% | 2,144,844 | 143,796 | |
VYNE | VYNE Therapeutics Inc | 2025-03-31 | Add Add | +0.35% | 1.58 ($2.46) 4.28 | $1.16 | -52.85% | Add 71.99% | 785,938 | 328,968 | |
MURA | Mural Oncology PLC | 2025-03-31 | Reduce Reduce | -0.03% | 1.18 ($3.65) 4.47 | $2.50 | -31.51% | Reduce -1.27% | 1,269,715 | -16,364 | |
WHWK | Whitehawk Therapeutics Inc | 2025-03-31 | Reduce Reduce | -0.01% | 1.78 ($2.61) 3.73 | $1.80 | -31.03% | Reduce -0.67% | 1,139,363 | -7,689 |
ACORN CAPITAL ADVISORS, LLC Total Holding History ($B)
ACORN CAPITAL ADVISORS, LLC's Asset Allocation
ACORN CAPITAL ADVISORS, LLC Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
ACORN CAPITAL ADVISORS, LLC's Hypothetical Growth since 2025-03-31
ACORN CAPITAL ADVISORS, LLC's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
ACORN CAPITAL ADVISORS, LLC's Holdings Heat Map
Size field:
ACORN CAPITAL ADVISORS, LLC's Holdings Bubble Chart
ACORN CAPITAL ADVISORS, LLC News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers